UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 4, 2005
Accellent Corp.
(Exact Name of Registrant as Specified in Charter)
Colorado | | 333-118675 | | 91-2054669 |
(State or Other Jurisdiction
of Incorporation) | | (Commission
File Number) | | (IRS Employer
Identification No.) |
200 West 7th Avenue, Suite 200, Collegeville, PA 19426-0992
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (610) 489-0300
Medical Device Manufacturing, Inc.
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuan t to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On May 4, 2005, Accellent Corp., formerly known as Medical Device Manufacturing, Inc. (the “Company”), announced its financial results for its first quarter ended March 31, 2005. A copy of the earnings release is furnished to the United States Securities and Exchange Commission with this current report on Form 8-K as exhibit 99.1.
Item 8.01 Other Events.
On May 4, 2005, the Company filed an amendment to its Articles of Incorporation to change its name from Medical Device Manufacturing, Inc. to Accellent Corp.
Item 9.01 Financial Statements and Exhibits.
(a) | Financial statements of businesses acquired. |
(b) | Pro forma financial information. |
| Exhibit No. | | Exhibit Description |
| | | |
| 99.1 | | Earnings release dated May 4, 2005 furnished pursuant to Item 2.02 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ACCELLENT CORP. |
| |
| |
Date: May 4, 2005 | By: | /s/ STEWART A. FISHER | |
| Name: | Stewart A. Fisher |
| Title: | Chief Financial Officer, Vice President,
Treasurer and Secretary |
3
EXHIBIT INDEX
Exhibit No. | | Exhibit Description |
| | |
99.1 | | Earnings release dated May 4, 2005 furnished pursuant to Item 2.02 |
4
